Vaccine therapy for pancreatic cancer

  title={Vaccine therapy for pancreatic cancer},
  author={Bulent Salman and Donger Zhou and Elizabeth M. Jaffee and Barish H. Edil and Lei Zheng},
Pancreatic cancer is a lethal disease and currently available therapies have significant limitations. Pancreatic cancer is thus an ideal setting for the development of novel treatment modalities such as immunotherapy. However, relevant obstacles must be overcome for immunotherapeutic regimens against pancreatic cancer to be successful. Vaccine therapy relies on the administration of biological preparations that include an antigen that (at least ideally) is specifically expressed by malignant… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
15 Citations
49 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 15 extracted citations


Publications referenced by this paper.
Showing 1-10 of 49 references

Interim safety and efficacy analysis of a phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer

  • DT Le, A Wang-Gillam, VJ Picozzi, TF Greten, TS Crocenzi, M Gregory
  • J Clin Oncol
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…